130 related articles for article (PubMed ID: 1312008)
1. Synergistic induction of erythroid differentiation of mouse erythroleukemia (MEL) cells by inhibitors of topoisomerases and protein tyrosine kinases.
Watanabe T; Kume T; Tsuneizumi K; Kondo K; Shiraishi T; Oishi M
Exp Cell Res; 1992 Apr; 199(2):269-74. PubMed ID: 1312008
[TBL] [Abstract][Full Text] [Related]
2. Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases.
Watanabe T; Kondo K; Oishi M
Cancer Res; 1991 Feb; 51(3):764-8. PubMed ID: 1988116
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors for protein-tyrosine kinases, ST638 and genistein: induce differentiation of mouse erythroleukemia cells in a synergistic manner.
Watanabe T; Shiraishi T; Sasaki H; Oishi M
Exp Cell Res; 1989 Aug; 183(2):335-42. PubMed ID: 2767154
[TBL] [Abstract][Full Text] [Related]
4. Dephosphorylation of Vav is associated with the induction of mouse erythroleukemia cell differentiation: effects of orthovanadate and levamisole.
Scher BM; Wei XJ; Waxman S; Scher W
Int J Oncol; 1998 Jun; 12(6):1307-13. PubMed ID: 9592191
[TBL] [Abstract][Full Text] [Related]
5. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
[TBL] [Abstract][Full Text] [Related]
6. The phosphatase inhibitors, orthovanadate and levamisole, inhibit induction of erythroid differentiation and abrogate the associated inhibition of glycolysis.
Scher BM; Fuksina I; Hellinger N; Waxman S; Scher W
Int J Oncol; 1998 May; 12(5):987-96. PubMed ID: 9538118
[TBL] [Abstract][Full Text] [Related]
7. Evidence that a novel human differentiation-inhibiting protein blocks the dimethyl sulfoxide-induced differentiation of erythroleukemia cells by inhibiting the activation of membrane protein kinase C.
Durkin JP; Chakravarthy B; Tremblay R; Jouishomme H; Whitfield JF; Biquard JM; Krsmanovic V
Cancer Res; 1992 Nov; 52(22):6329-34. PubMed ID: 1423278
[TBL] [Abstract][Full Text] [Related]
8. C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells.
Poindessous-Jazat V; Augery-Bourget Y; Robert-Lézénès J
Leukemia; 2002 Feb; 16(2):233-43. PubMed ID: 11840290
[TBL] [Abstract][Full Text] [Related]
9. Alteration of phosphotyrosine-containing proteins at the early stage of erythroid differentiation of mouse erythroleukemia (MEL) cells.
Watanabe T; Kume T; Oishi M
J Biol Chem; 1992 Aug; 267(24):17116-20. PubMed ID: 1380959
[TBL] [Abstract][Full Text] [Related]
10. Benzyl alcohol alters the hemoglobin phenotype of mouse erythroleukemia cells.
Scher W; Scher BM; Hellinger N; Waxman S
J Biol Regul Homeost Agents; 1989; 3(3):91-7. PubMed ID: 2483024
[TBL] [Abstract][Full Text] [Related]
11. Bcl-XL is required for heme synthesis during the chemical induction of erythroid differentiation of murine erythroleukemia cells independently of its antiapoptotic function.
Hafid-Medheb K; Augery-Bourget Y; Minatchy MN; Hanania N; Robert-Lézénès J
Blood; 2003 Apr; 101(7):2575-83. PubMed ID: 12446462
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of erythroid and megakaryocytic differentiation in Friend erythroleukemia cells.
Hyman T; Rothmann C; Heller A; Malik Z; Salzberg S
Exp Hematol; 2001 May; 29(5):563-71. PubMed ID: 11376868
[TBL] [Abstract][Full Text] [Related]
13. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
14. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
16. Effect of mitochondrial protein synthesis inhibitors on erythroid differentiation of mouse erythroleukemia (Friend) cells.
Kaneko T; Watanabe T; Oishi M
Mol Cell Biol; 1988 Aug; 8(8):3311-5. PubMed ID: 3211144
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl sulfoxide-inducible cytoplasmic factor involved in erythroid differentiation in mouse erythroleukemia (Friend) cells.
Watanabe T; Oishi M
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6481-5. PubMed ID: 3476957
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase activity in murine erythroleukemia cells during DMSO-induced differentiation.
Ai Z; Misra S; Susa M; Varticovski L; Cohen CM
Exp Cell Res; 1995 Aug; 219(2):454-60. PubMed ID: 7641797
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation.
Melloni E; Pontremoli S; Michetti M; Sacco O; Cakiroglu AG; Jackson JF; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5282-6. PubMed ID: 3474654
[TBL] [Abstract][Full Text] [Related]
20. Lipid changes associated with erythroid differentiation of Friend erythroleukemia cells.
Fallani A; Arcangeli A; Ruggieri S
Toxicol Pathol; 1987; 15(2):170-7. PubMed ID: 3475757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
